Cargando…
Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Seventy-one patients suffering from acute myeloid leukaemia (AML) who were already in complete remission and had already received one further course of cytotoxic drugs as consolidation therapy were randomised to receive maintenance chemotherapy alone or the same maintenance chemotherapy plus immunot...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1978
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009501/ https://www.ncbi.nlm.nih.gov/pubmed/339940 |
Ejemplares similares
-
Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
Publicado: (1979) -
Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975) -
Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019) -
A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.
por: Cuzick, J., et al.
Publicado: (1987) -
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
por: Casirati, Gabriele, et al.
Publicado: (2023)